TherapeuticsMD Inc (TXMD)
2.13
+0.04
(+1.91%)
USD |
NASDAQ |
May 22, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
TherapeuticsMD Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.002M |
| September 30, 2023 | -0.001M |
| June 30, 2023 | 1.15M |
| March 31, 2023 | |
| December 31, 2022 | -111.94M |
| September 30, 2022 | 1.739M |
| June 30, 2022 | -120.00M |
| March 31, 2022 | -5.00M |
| December 31, 2021 | 1.353M |
| September 30, 2021 | 31.82M |
| June 30, 2021 | 0.428M |
| March 31, 2021 | 95.95M |
| December 31, 2020 | 31.70M |
| September 30, 2020 | 0.106M |
| June 30, 2020 | 0.094M |
| March 31, 2020 | 48.82M |
| December 31, 2019 | 77.03M |
| September 30, 2019 | 0.0085M |
| June 30, 2019 | 111.69M |
| March 31, 2019 | 0.1001M |
| December 31, 2018 | 0.4299M |
| September 30, 2018 | 90.02M |
| June 30, 2018 | 72.30M |
| March 31, 2018 | 0.0441M |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 68.57M |
| June 30, 2017 | 1.359M |
| March 31, 2017 | 2.652M |
| December 31, 2016 | 0.01M |
| September 30, 2016 | 0.001M |
| June 30, 2016 | 0.2546M |
| March 31, 2016 | 136.96M |
| December 31, 2015 | 0.6428M |
| September 30, 2015 | 32.36M |
| June 30, 2015 | 0.4917M |
| March 31, 2015 | 59.48M |
| December 31, 2014 | 0.0302M |
| September 30, 2014 | 42.89M |
| June 30, 2014 | 0.3342M |
| March 31, 2014 | 0.0401M |
| December 31, 2013 | -0.3099M |
| September 30, 2013 | 30.47M |
| June 30, 2013 | 2.988M |
| March 31, 2013 | 40.84M |
| December 31, 2012 | 5.521M |
| September 30, 2012 | 1.95M |
| June 30, 2012 | 4.400M |
| March 31, 2012 | 2.565M |
| December 31, 2011 | 1.856M |
| September 30, 2011 | 1.347M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-120.00M
Minimum
Jun 2022
111.69M
Maximum
Jun 2019
9.275M
Average
1.252M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.229M |
| Free Cash Flow | -14.61M |
| Free Cash Flow Per Share (Quarterly) | -0.0199 |
| Free Cash Flow to Equity (Quarterly) | -0.229M |
| Free Cash Flow to Firm (Quarterly) | -0.229M |
| Free Cash Flow Yield | -63.08% |